Peer-reviewed veterinary case report
Wound healing after mast cell tumor treatment in dogs with tigilanol
By Reddell, Paul et al.·Published in Journal of veterinary internal medicine·2021·QBiotics Group Limited, Australia·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate.
- Species:
- dog
Plain-English summary
A group of dogs with nonmetastatic mast cell tumors (a type of skin cancer) received a single treatment with tigilanol tiglate (TT) directly into the tumor. After treatment, most dogs experienced sloughing of the tumor within 3 to 14 days, revealing a wound that typically healed well over the next few weeks. By 28 days, 75% of the dogs had no signs of the tumor returning, and 93% remained tumor-free at 84 days. Most wounds healed naturally without the need for bandaging, and the healing time varied based on the size and location of the wound.
People also search for: dog mast cell tumor treatment · tigilanol tiglate for dogs · dog skin cancer healing time
Abstract
BACKGROUND: Tigilanol tiglate (TT) is a novel small molecule for intratumoral treatment of nonmetastatic mast cell tumors (MCTs) in dogs. In a randomized controlled clinical study, 75% of dogs that received a single TT treatment achieved complete resolution of the MCT by 28 days, with no recurrence in 93% of dogs at 84 days. Critical to TT's efficacy was the area of the wound (tissue deficit) after slough of the necrotic tumor relative to pretreatment tumor volume. OBJECTIVES: To analyze data collected during the previous study to (a) describe wounds after slough of treated MCTs and (b) identify determinants of wound area and speed of wound healing. METHODS: Wound presence, condition, and area were determined from clinical records of 117 dogs over 84 days after a single intratumoral TT treatment. RESULTS: Tumor slough occurred 3 to 14 days after treatment, exposing granulation tissue in the wound bed. Wound area after tumor slough in general was related to pretreatment tumor volume, with maximal recorded wound area fully evident in 89% of dogs by day 7. In dogs achieving complete tumor resolution, all wounds were left to heal by secondary intention. Bandaging and other wound management interventions only were required in 5 dogs. Time to healing (ie, full re-epithelialization of treatment site) depended on wound area and location on the body, with most wounds being fully healed between 28 and 42 days after treatment. CONCLUSIONS: Wound area and healing after slough of TT-treated tumors follow a consistent clinical pattern for most dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33438258/